Group is primarily involved in the importing and selling of pharmaceuticals, managing portfolio of investments, marketing of tea, palm oil and related products.
Net asset per share group...25.99
Stated capital to equity ratio....10
EPS quarter...1.44
EPS period(6m)...2.69
Cash flow...stable
Lamurep Investments Limited has increased the stake from 51.09% to 59.48%
PAT for the period(sep 2021)...2,456,759,270
Contribution from agri......1,888,688,000 (contribution from palm oil 1,828,155,000)
Contribution from health...507,383,929
Contribution from investment and management....807,411,471
PAT for the period(sep 2020).....1,285,384,103
Contribution from agri......917,500,000 (contribution from palm oil 861,602,000)
Contribution from health...423,437,178
Contribution from investment and management....915,635,783
PAT for the year ended Mar 31, 2021....2,537,528,001
Contribution from agri....1,662,836,000(contribution from palm oil 1,583,638,000)
Contribution from health...823,571,228
PAT for the year ended Mar 31, 2020.......1,832,637,567
Contribution from agri....755,299,238 (contribution from palm oil 909,172,000)
Contribution from health...509,637,769
Compared to the year ended Mar 31, 2020, the contribution from health in 2022(year ended Mar 31, 2022)will be doubled?
Compared to the year ended Mar 31, 2021, the contribution from palm oil in 2022(year ended Mar 31, 2022)will be doubled?
PAT from palm oil
Sep 2021...1,135,646,000
Jun 2021...692,509,000
Mar 2021...421,211,000
Dec 2020....300,825,000
Sep 2020....470,935,000
Jun 2020....390,667,000
Mar 2020...42,031,000